SCHEMBL25919142

SCHEMBL25919142

Cc1cccc(C)c1-n1c2ccccc2c2c1n(C)c(C)[n+]2N

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.40
FTO Q9C0B1 1/20 0.40
NTRK1 P04629 1/20 0.34
GPR3 P46089 1/20 0.33
KDM4E B2RXH2 3/20 0.33
NQO2 P16083 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPSR1 Q6W5P4 2/20 0.31
KMT2A Q03164 1/20 0.30
NPEPPS P55786 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919143 0.79 ALKBH5 (0.44) ALKBH5FTONTRK1GPR3KDM4E
SCHEMBL19233941 0.71 ALKBH5 (0.45) ALKBH5FTONTRK1GPR3KDM4E
SCHEMBL2958307 0.71 ALKBH5 (0.53) ALKBH5FTOGPR3KDM4ENQO2
SCHEMBL19233789 0.70 ALKBH5 (0.41) ALKBH5FTONTRK1GPR3KDM4E
SCHEMBL19233681 0.70 ALKBH5 (0.41) ALKBH5FTONTRK1GPR3KDM4E
SCHEMBL19233939 0.69 LIMK1 (0.40) ALKBH5FTONTRK1KDM4EMAPT
SCHEMBL25912327 0.69 ALKBH5 (0.41) ALKBH5FTOGPR3KDM4ENQO2
SCHEMBL25911951 0.68 LCK (0.41) ALKBH5FTO
SCHEMBL25912357 0.67 ALKBH5 (0.33) ALKBH5FTOALDH1A1HSD17B10KMT2A
SCHEMBL25912354 0.67 GAA (0.34) KDM4EMAPTALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND ALKBH5 595/4885FTO 61/4885NTRK1 4123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.